Publication | Open Access
Antitumor activity and safety of pembrolizumab in patients with advanced recurrent ovarian cancer: results from the phase II KEYNOTE-100 study
786
Citations
18
References
2019
Year
Antitumor ActivityOncologyMedicineGynecologyImmune Checkpoint InhibitorAnti-cancer AgentCancer TreatmentPharmacologyOvarian Cancer
| Year | Citations | |
|---|---|---|
Page 1
Page 1